Skip to main content
. 2021 Oct 7;14(1):79–89. doi: 10.1016/j.chmed.2021.10.002

Fig. 1.

Fig. 1

Pathological features of transplanted tumors in mice bearing H22 hepatocellular carcinoma after different treatments (×400, A). Weight of H22 tumor in different groups (B, mean ± SD, n = 8). Inhibition effects of each drug on H22 hepatocellular carcinoma in the mice (C). Bodyweight increase of the mice in different groups (D) (mean ± SD, n = 8). *P < 0.05 vs model group. ^P < 0.05 vs CTX alone group.